Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development
Baojun Chang,
Kandice L. Tessneer,
John McManus,
Xiaolei Liu,
Scott Hahn,
Satish Pasula,
Hao Wu,
Hoogeun Song,
Yiyuan Chen,
Xiaofeng Cai,
Yunzhou Dong,
Megan L. Brophy,
Ruby Rahman,
Jian-Xing Ma,
Lijun Xia and
Hong Chen ()
Additional contact information
Baojun Chang: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Kandice L. Tessneer: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
John McManus: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Xiaolei Liu: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Scott Hahn: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Satish Pasula: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Hao Wu: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Hoogeun Song: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Yiyuan Chen: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Xiaofeng Cai: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Yunzhou Dong: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Megan L. Brophy: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Ruby Rahman: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Jian-Xing Ma: Harold Hamm Oklahoma Diabetes Center, University of Oklahoma Health Sciences Center
Lijun Xia: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Hong Chen: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Nature Communications, 2015, vol. 6, issue 1, 1-17
Abstract:
Abstract Uncontrolled canonical Wnt signalling supports colon epithelial tumour expansion and malignant transformation. Understanding the regulatory mechanisms involved is crucial for elucidating the pathogenesis of and will provide new therapeutic targets for colon cancer. Epsins are ubiquitin-binding adaptor proteins upregulated in several human cancers; however, the involvement of epsins in colon cancer is unknown. Here we show that loss of intestinal epithelial epsins protects against colon cancer by significantly reducing the stability of the crucial Wnt signalling effector, dishevelled (Dvl2), and impairing Wnt signalling. Consistently, epsins and Dvl2 are correspondingly upregulated in colon cancer. Mechanistically, epsin binds Dvl2 via its epsin N-terminal homology domain and ubiquitin-interacting motifs and prohibits Dvl2 polyubiquitination and degradation. Our findings reveal an unconventional role for epsins in stabilizing Dvl2 and potentiating Wnt signalling in colon cancer cells to ensure robust colon cancer progression. The pro-carcinogenic role of Epsins suggests that they are potential therapeutic targets to combat colon cancer.
Date: 2015
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/ncomms7380 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7380
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/ncomms7380
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().